Previous studies have demonstrated that HDAC2 expression is specifically increased in neurons in the AD brain using immunohistochemical approaches and HDAC inhibition may have therapeutic potential for neurodegenerative disease [3,43]. This evidence concerns the gene HDAC9 and Alzheimer disease.